LymphedemaV1, PascalFrancis, Curation, bibRecord, 000440

Risk of decline in upper-body function and symptoms among older breast cancer patients

Identifieur interne : 000440 ( PascalFrancis/Curation ); précédent : 000439; suivant : 000441

Risk of decline in upper-body function and symptoms among older breast cancer patients

Auteurs : Jennifer L. Westrup [États-Unis] ; Timothy L. Lash [États-Unis] ; Soe Soe Thwin [États-Unis] ; Rebecca A. Silliman [États-Unis]

Source :

Journal of general internal medicine [ 0884-8734 ] ; 2006.

RBID : Pascal:06-0373679

Descripteurs français

Pascal (Inist)
- Tumeur maligne, Facteur risque, Lymphoedème, Epidémiologie, Symptomatologie, Personne âgée, Age, Glande mammaire, Malade, Complication, Traitement, Médecine, Cancer sein, Tumeur sein.
Wicri :
- topic : Personne âgée, Médecine.

English descriptors

KwdEn :
- Age, Breast cancer, Breast tumor, Complication, Elderly, Epidemiology, Lymphedema, Malignant tumor, Mammary gland, Medicine, Patient, Risk factor, Symptomatology, Treatment.

Abstract

BACKGROUND: Decline In upper-body function and development of upper-body symptoms are adverse effects of breast cancer therapy and may affect functional independence, particularly among older survivors. The long-term risks and predictors are poorly understood. OBJECTIVE: To characterize the risk of decline in upper-body function and development of symptoms over 4 years of follow-up. DESIGN; We used a prospective cohort design. PARTICIPANTS: Six hundred and forty-four early stage breast cancer patients 65 years old or older at surgery enrolled In Rhode Island, North Carolina, Minnesota, and Los Angeles between 1996 and 1999. MEASUREMENTS: Upper-body function and symptoms were self-reported at baseline, 6, 15 months, and annually thereafter to 51 months' after surgery. RESULTS: One half of the participants had a decline in upper-body function and one-quarter developed upper-body symptoms. Breast cancer patients were 5-fold more likely to have a decline in upper-body function over 4 years of follow-up than a similar cohort without breast cancer. Better baseline mental health protected against a decline in upper-body function (odds ratio [OR]=0.93, 95% confidence interval [CI] 0.88 to 0.97 for 8-point higher mental health index). Baseline obesity (OR for body mass index [BMI] ≥ 30 kg/m² vs <30 kg/m²=2.5, CI=1.6 to 4.0) and axillary node dissection (OR for axillary dissection vs not =3.9, CI=1.1 to 14) predicted the development of upper-body symptoms. CONCLUSIONS: Primary care physicians should address upper-body function and symptoms with older breast cancer patients, and Inform them that these complications of breast cancer treatment are common.

A01	`01`	`1`		`@0 0884-8734`
A03		`1`		`@0 J. gen. intern. med.`
A05				`@2 21`
A06				`@2 4`
A08	`01`	`1`	`ENG`	`@1 Risk of decline in upper-body function and symptoms among older breast cancer patients`
A11	`01`	`1`		`@1 WESTRUP (Jennifer L.)`
A11	`02`	`1`		`@1 LASH (Timothy L.)`
A11	`03`	`1`		`@1 THWIN (Soe Soe)`
A11	`04`	`1`		`@1 SILLIMAN (Rebecca A.)`
A14	`01`			`@1 Hematology and Medical Oncology Section, Department of Medicine, Boston University School of Medicine @2 Boston, MA @3 USA @Z 1 aut.`
A14	`02`			`@1 Geriatrics Section, Department of Medicine, Boston University School of Medicine @2 Boston, MA @3 USA @Z 2 aut. @Z 3 aut. @Z 4 aut.`
A14	`03`			`@1 Department of Epidemiology, Boston University School of Public Health @2 Boston, MA @3 USA @Z 2 aut. @Z 4 aut.`
A20				`@1 327-333`
A21				`@1 2006`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 21819 @5 354000153169960080`
A44				`@0 0000 @1 © 2006 INIST-CNRS. All rights reserved.`
A45				`@0 38 ref.`
A47	`01`	`1`		`@0 06-0373679`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of general internal medicine`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 BACKGROUND: Decline In upper-body function and development of upper-body symptoms are adverse effects of breast cancer therapy and may affect functional independence, particularly among older survivors. The long-term risks and predictors are poorly understood. OBJECTIVE: To characterize the risk of decline in upper-body function and development of symptoms over 4 years of follow-up. DESIGN; We used a prospective cohort design. PARTICIPANTS: Six hundred and forty-four early stage breast cancer patients 65 years old or older at surgery enrolled In Rhode Island, North Carolina, Minnesota, and Los Angeles between 1996 and 1999. MEASUREMENTS: Upper-body function and symptoms were self-reported at baseline, 6, 15 months, and annually thereafter to 51 months' after surgery. RESULTS: One half of the participants had a decline in upper-body function and one-quarter developed upper-body symptoms. Breast cancer patients were 5-fold more likely to have a decline in upper-body function over 4 years of follow-up than a similar cohort without breast cancer. Better baseline mental health protected against a decline in upper-body function (odds ratio [OR]=0.93, 95% confidence interval [CI] 0.88 to 0.97 for 8-point higher mental health index). Baseline obesity (OR for body mass index [BMI] ≥ 30 kg/m² vs <30 kg/m²=2.5, CI=1.6 to 4.0) and axillary node dissection (OR for axillary dissection vs not =3.9, CI=1.1 to 14) predicted the development of upper-body symptoms. CONCLUSIONS: Primary care physicians should address upper-body function and symptoms with older breast cancer patients, and Inform them that these complications of breast cancer treatment are common.
C02	`01`	`X`		`@0 002B30A11`
C02	`02`	`X`		`@0 002B01`
C02	`03`	`X`		`@0 002B20E02`
C03	`01`	`X`	`FRE`	`@0 Tumeur maligne @5 01`
C03	`01`	`X`	`ENG`	`@0 Malignant tumor @5 01`
C03	`01`	`X`	`SPA`	`@0 Tumor maligno @5 01`
C03	`02`	`X`	`FRE`	`@0 Facteur risque @5 02`
C03	`02`	`X`	`ENG`	`@0 Risk factor @5 02`
C03	`02`	`X`	`SPA`	`@0 Factor riesgo @5 02`
C03	`03`	`X`	`FRE`	`@0 Lymphoedème @5 03`
C03	`03`	`X`	`ENG`	`@0 Lymphedema @5 03`
C03	`03`	`X`	`SPA`	`@0 Linfedema @5 03`
C03	`04`	`X`	`FRE`	`@0 Epidémiologie @5 05`
C03	`04`	`X`	`ENG`	`@0 Epidemiology @5 05`
C03	`04`	`X`	`SPA`	`@0 Epidemiología @5 05`
C03	`05`	`X`	`FRE`	`@0 Symptomatologie @5 08`
C03	`05`	`X`	`ENG`	`@0 Symptomatology @5 08`
C03	`05`	`X`	`SPA`	`@0 Sintomatología @5 08`
C03	`06`	`X`	`FRE`	`@0 Personne âgée @5 09`
C03	`06`	`X`	`ENG`	`@0 Elderly @5 09`
C03	`06`	`X`	`SPA`	`@0 Anciano @5 09`
C03	`07`	`X`	`FRE`	`@0 Age @5 11`
C03	`07`	`X`	`ENG`	`@0 Age @5 11`
C03	`07`	`X`	`SPA`	`@0 Edad @5 11`
C03	`08`	`X`	`FRE`	`@0 Glande mammaire @5 12`
C03	`08`	`X`	`ENG`	`@0 Mammary gland @5 12`
C03	`08`	`X`	`SPA`	`@0 Glándula mamaria @5 12`
C03	`09`	`X`	`FRE`	`@0 Malade @5 18`
C03	`09`	`X`	`ENG`	`@0 Patient @5 18`
C03	`09`	`X`	`SPA`	`@0 Enfermo @5 18`
C03	`10`	`X`	`FRE`	`@0 Complication @5 19`
C03	`10`	`X`	`ENG`	`@0 Complication @5 19`
C03	`10`	`X`	`SPA`	`@0 Complicación @5 19`
C03	`11`	`X`	`FRE`	`@0 Traitement @5 20`
C03	`11`	`X`	`ENG`	`@0 Treatment @5 20`
C03	`11`	`X`	`SPA`	`@0 Tratamiento @5 20`
C03	`12`	`X`	`FRE`	`@0 Médecine @5 21`
C03	`12`	`X`	`ENG`	`@0 Medicine @5 21`
C03	`12`	`X`	`SPA`	`@0 Medicina @5 21`
C03	`13`	`X`	`FRE`	`@0 Cancer sein @4 CD @5 96`
C03	`13`	`X`	`ENG`	`@0 Breast cancer @4 CD @5 96`
C03	`13`	`X`	`SPA`	`@0 Cáncer pecho @4 CD @5 96`
C03	`14`	`X`	`FRE`	`@0 Tumeur sein @4 CD @5 97`
C03	`14`	`X`	`ENG`	`@0 Breast tumor @4 CD @5 97`
C03	`14`	`X`	`SPA`	`@0 Tumor pecho @4 CD @5 97`
C07	`01`	`X`	`FRE`	`@0 Homme`
C07	`01`	`X`	`ENG`	`@0 Human`
C07	`01`	`X`	`SPA`	`@0 Hombre`
C07	`02`	`X`	`FRE`	`@0 Glande mammaire pathologie @2 NM @5 37`
C07	`02`	`X`	`ENG`	`@0 Mammary gland diseases @2 NM @5 37`
C07	`02`	`X`	`SPA`	`@0 Glándula mamaria patología @2 NM @5 37`
C07	`03`	`X`	`FRE`	`@0 Appareil circulatoire pathologie @5 38`
C07	`03`	`X`	`ENG`	`@0 Cardiovascular disease @5 38`
C07	`03`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 38`
C07	`04`	`X`	`FRE`	`@0 Lymphatique pathologie @5 39`
C07	`04`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 39`
C07	`04`	`X`	`SPA`	`@0 Linfático patología @5 39`
N21				`@1 247`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000520

Links to Exploration step

Pascal:06-0373679

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk of decline in upper-body function and symptoms among older breast cancer patients</title>
<author><name sortKey="Westrup, Jennifer L" sort="Westrup, Jennifer L" uniqKey="Westrup J" first="Jennifer L." last="Westrup">Jennifer L. Westrup</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hematology and Medical Oncology Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Lash, Timothy L" sort="Lash, Timothy L" uniqKey="Lash T" first="Timothy L." last="Lash">Timothy L. Lash</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology, Boston University School of Public Health</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Thwin, Soe Soe" sort="Thwin, Soe Soe" uniqKey="Thwin S" first="Soe Soe" last="Thwin">Soe Soe Thwin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Silliman, Rebecca A" sort="Silliman, Rebecca A" uniqKey="Silliman R" first="Rebecca A." last="Silliman">Rebecca A. Silliman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology, Boston University School of Public Health</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">06-0373679</idno>
<date when="2006">2006</date>
<idno type="stanalyst">PASCAL 06-0373679 INIST</idno>
<idno type="RBID">Pascal:06-0373679</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000520</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000440</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk of decline in upper-body function and symptoms among older breast cancer patients</title>
<author><name sortKey="Westrup, Jennifer L" sort="Westrup, Jennifer L" uniqKey="Westrup J" first="Jennifer L." last="Westrup">Jennifer L. Westrup</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Hematology and Medical Oncology Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Lash, Timothy L" sort="Lash, Timothy L" uniqKey="Lash T" first="Timothy L." last="Lash">Timothy L. Lash</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology, Boston University School of Public Health</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Thwin, Soe Soe" sort="Thwin, Soe Soe" uniqKey="Thwin S" first="Soe Soe" last="Thwin">Soe Soe Thwin</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Silliman, Rebecca A" sort="Silliman, Rebecca A" uniqKey="Silliman R" first="Rebecca A." last="Silliman">Rebecca A. Silliman</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Epidemiology, Boston University School of Public Health</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of general internal medicine</title>
<title level="j" type="abbreviated">J. gen. intern. med.</title>
<idno type="ISSN">0884-8734</idno>
<imprint><date when="2006">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of general internal medicine</title>
<title level="j" type="abbreviated">J. gen. intern. med.</title>
<idno type="ISSN">0884-8734</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age</term>
<term>Breast cancer</term>
<term>Breast tumor</term>
<term>Complication</term>
<term>Elderly</term>
<term>Epidemiology</term>
<term>Lymphedema</term>
<term>Malignant tumor</term>
<term>Mammary gland</term>
<term>Medicine</term>
<term>Patient</term>
<term>Risk factor</term>
<term>Symptomatology</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Tumeur maligne</term>
<term>Facteur risque</term>
<term>Lymphoedème</term>
<term>Epidémiologie</term>
<term>Symptomatologie</term>
<term>Personne âgée</term>
<term>Age</term>
<term>Glande mammaire</term>
<term>Malade</term>
<term>Complication</term>
<term>Traitement</term>
<term>Médecine</term>
<term>Cancer sein</term>
<term>Tumeur sein</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Personne âgée</term>
<term>Médecine</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">BACKGROUND: Decline In upper-body function and development of upper-body symptoms are adverse effects of breast cancer therapy and may affect functional independence, particularly among older survivors. The long-term risks and predictors are poorly understood. OBJECTIVE: To characterize the risk of decline in upper-body function and development of symptoms over 4 years of follow-up. DESIGN; We used a prospective cohort design. PARTICIPANTS: Six hundred and forty-four early stage breast cancer patients 65 years old or older at surgery enrolled In Rhode Island, North Carolina, Minnesota, and Los Angeles between 1996 and 1999. MEASUREMENTS: Upper-body function and symptoms were self-reported at baseline, 6, 15 months, and annually thereafter to 51 months' after surgery. RESULTS: One half of the participants had a decline in upper-body function and one-quarter developed upper-body symptoms. Breast cancer patients were 5-fold more likely to have a decline in upper-body function over 4 years of follow-up than a similar cohort without breast cancer. Better baseline mental health protected against a decline in upper-body function (odds ratio [OR]=0.93, 95% confidence interval [CI] 0.88 to 0.97 for 8-point higher mental health index). Baseline obesity (OR for body mass index [BMI] ≥ 30 kg/m<sup>2</sup>
 vs <30 kg/m<sup>2</sup>
=2.5, CI=1.6 to 4.0) and axillary node dissection (OR for axillary dissection vs not =3.9, CI=1.1 to 14) predicted the development of upper-body symptoms. CONCLUSIONS: Primary care physicians should address upper-body function and symptoms with older breast cancer patients, and Inform them that these complications of breast cancer treatment are common.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0884-8734</s0>
</fA01>
<fA03 i2="1"><s0>J. gen. intern. med.</s0>
</fA03>
<fA05><s2>21</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Risk of decline in upper-body function and symptoms among older breast cancer patients</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WESTRUP (Jennifer L.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>LASH (Timothy L.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>THWIN (Soe Soe)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>SILLIMAN (Rebecca A.)</s1>
</fA11>
<fA14 i1="01"><s1>Hematology and Medical Oncology Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Geriatrics Section, Department of Medicine, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Epidemiology, Boston University School of Public Health</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>327-333</s1>
</fA20>
<fA21><s1>2006</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>21819</s2>
<s5>354000153169960080</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2006 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>06-0373679</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of general internal medicine</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>BACKGROUND: Decline In upper-body function and development of upper-body symptoms are adverse effects of breast cancer therapy and may affect functional independence, particularly among older survivors. The long-term risks and predictors are poorly understood. OBJECTIVE: To characterize the risk of decline in upper-body function and development of symptoms over 4 years of follow-up. DESIGN; We used a prospective cohort design. PARTICIPANTS: Six hundred and forty-four early stage breast cancer patients 65 years old or older at surgery enrolled In Rhode Island, North Carolina, Minnesota, and Los Angeles between 1996 and 1999. MEASUREMENTS: Upper-body function and symptoms were self-reported at baseline, 6, 15 months, and annually thereafter to 51 months' after surgery. RESULTS: One half of the participants had a decline in upper-body function and one-quarter developed upper-body symptoms. Breast cancer patients were 5-fold more likely to have a decline in upper-body function over 4 years of follow-up than a similar cohort without breast cancer. Better baseline mental health protected against a decline in upper-body function (odds ratio [OR]=0.93, 95% confidence interval [CI] 0.88 to 0.97 for 8-point higher mental health index). Baseline obesity (OR for body mass index [BMI] ≥ 30 kg/m<sup>2</sup>
 vs <30 kg/m<sup>2</sup>
=2.5, CI=1.6 to 4.0) and axillary node dissection (OR for axillary dissection vs not =3.9, CI=1.1 to 14) predicted the development of upper-body symptoms. CONCLUSIONS: Primary care physicians should address upper-body function and symptoms with older breast cancer patients, and Inform them that these complications of breast cancer treatment are common.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B30A11</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B01</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B20E02</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Symptomatologie</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Symptomatology</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Sintomatología</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Personne âgée</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Elderly</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Anciano</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Age</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Age</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Edad</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Glande mammaire</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Mammary gland</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Glándula mamaria</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Malade</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Patient</s0>
<s5>18</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Enfermo</s0>
<s5>18</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Complication</s0>
<s5>19</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Complication</s0>
<s5>19</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Complicación</s0>
<s5>19</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Traitement</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Treatment</s0>
<s5>20</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>20</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE"><s0>Médecine</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG"><s0>Medicine</s0>
<s5>21</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA"><s0>Medicina</s0>
<s5>21</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE"><s0>Cancer sein</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG"><s0>Breast cancer</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA"><s0>Cáncer pecho</s0>
<s4>CD</s4>
<s5>96</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE"><s0>Tumeur sein</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG"><s0>Breast tumor</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA"><s0>Tumor pecho</s0>
<s4>CD</s4>
<s5>97</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Homme</s0>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Human</s0>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Hombre</s0>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Glande mammaire pathologie</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Appareil circulatoire pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Lymphatique pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>39</s5>
</fC07>
<fN21><s1>247</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000440 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000440 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:06-0373679
   |texte=   Risk of decline in upper-body function and symptoms among older breast cancer patients
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Risk of decline in upper-body function and symptoms among older breast cancer patients

Risk of decline in upper-body function and symptoms among older breast cancer patients

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri